Andrew Wilder Inc – Trademark Portfolio

Entity Type: 03

Andrew Wilder Inc holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LENDGO, FETCHARATE, and WALLETADVISOR. The owner is based in Huntington Beach, CA.

9692 Melinda Circle

Huntington Beach, CA 92646

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Andrew Wilder Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (4 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Andrew Wilder Inc have?

Andrew Wilder Inc has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.

What trademark classes does Andrew Wilder Inc file in?

Andrew Wilder Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Andrew Wilder Inc's most well-known trademarks?

Andrew Wilder Inc's registered trademark portfolio includes well-known marks such as LENDGO, FETCHARATE, and WALLETADVISOR. These are among 3 currently registered trademarks in the portfolio.

What is Andrew Wilder Inc's trademark registration success rate?

Andrew Wilder Inc has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.